| P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide. | |
| | |
MedLine Citation:
|
PMID: 20237038 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
METHODS: Seventeen healthy volunteers had a total of 23 PET scans with (11)C-dLop at baseline and after increasing doses of tariquidar (2, 4, and 6 mg/kg intravenously). A subset of subjects received PET with (15)O-H(2)O to measure cerebral blood flow. Brain uptake of (11)C-dLop was quantified in 2 ways. Without blood data, uptake was measured as area under the time-activity curve in the brain from 10 to 30 min (AUC(10-30)). With arterial blood data, brain uptake was quantified with compartmental modeling to estimate the rates of entry into (K(1)) and efflux from (k(2)) the brain. RESULTS: Brain uptake of radioactivity was negligible at baseline and increased only slightly (approximately 30%) after 2 mg of tariquidar per kilogram. In contrast, 4 and 6 mg of tariquidar per kilogram increased brain uptake 2- and 4-fold, respectively. Greater brain uptake reflected greater brain entry (K(1)), because efflux (k(2)) and cerebral blood flow did not differ between tariquidar-treated and untreated subjects. In the subjects who received the highest dose of tariquidar (and had the highest brain uptake), regional values of K(1) correlated linearly with absolute cerebral blood flow, consistent with high single-pass extraction of (11)C-dLop. AUC(10-30) correlated linearly with K(1). CONCLUSION: P-gp function at the blood-brain barrier in humans can be quantified using PET and (11)C-dLop. A simple measure of brain uptake (AUC(10-30)) may be used as a surrogate of the fully quantified rate constant for brain entry (K(1)) and thereby avoid arterial sampling. However, to dissect the function of P-gp itself, both brain uptake and the influx rate constant must be corrected for radiotracer delivery (blood flow). |
| | |
Authors:
|
William C Kreisl; Jeih-San Liow; Nobuyo Kimura; Nicholas Seneca; Sami S Zoghbi; Cheryl L Morse; Peter Herscovitch; Victor W Pike; Robert B Innis |
Related Documents
:
|
3192638 - The retention of [99mtc]-d,l-hm-pao in the human brain after intracarotid bolus injecti... 6681598 - Cerebral blood flow and cerebral metabolism in normal and intrauterine growth retarded ... 1899528 - The role of xenon ct measurements of cerebral blood flow in the clinical determination ... 3680508 - Apparent tolerance to the acute effect of nicotine results in part from distribution ki... 16215388 - Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculat... 9486448 - Preoperative vascular assessment: an aid to radial forearm surgery. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural Date: 2010-03-17 |
Journal Detail:
|
Title: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Volume: 51 ISSN: 1535-5667 ISO Abbreviation: J. Nucl. Med. Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-03-30 Completed Date: 2010-04-19 Revised Date: 2010-12-03 |
Medline Journal Info:
|
Nlm Unique ID: 0217410 Medline TA: J Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 559-66 Citation Subset: IM |
Affiliation:
|
Molecular Imaging Branch, National Institute of Mental Health, Bethesda, Maryland 20892, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biological Transport / drug effects Blood-Brain Barrier / drug effects, metabolism*, physiology, radionuclide imaging Cerebrovascular Circulation / drug effects Dose-Response Relationship, Drug Drug Toxicity Female Humans Kinetics Loperamide / analogs & derivatives*, metabolism Magnetic Resonance Imaging Male P-Glycoproteins / antagonists & inhibitors, metabolism* Positron-Emission Tomography Quinolines / pharmacology Radioactive Tracers |
| Grant Support | |
ID/Acronym/Agency:
|
Z01 MH002852-04/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/N-demethylloperamide; 0/P-Glycoproteins; 0/Quinolines; 0/Radioactive Tracers; 206873-63-4/tariquidar; 53179-11-6/Loperamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung.
Next Document: 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Inte...